AstraZeneca Says New COVID Drug Works Against Omicron Subvariants - The Daily Beast

New pharmaceutical also works against super-infections Omicron variants, according to a U.S. study.

AstraZeneca says its new COVID drug Evusheld also works against the Omicron variant and its super-infectious BA.2 subvariant, which is rapidly becoming the major strain of the coronavirus around the … [+631 chars]

full article...